News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Cannasat Therapeutics Inc. Reports Results for the Six Months Ended June 30, 2008
August 29, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO, ONTARIO--(Marketwire - August 29, 2008) - Cannasat Therapeutics Inc. (TSX VENTURE: CTH), a CNS drug development company, today announced its results for the six months ended June 30, 2008.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
MindMaze trims Relief staff, Aardvark cuts workforce amid Prader-Willi troubles
August 13, 2026
·
83 min read
·
BioSpace Editorial Staff
Rare diseases
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
August 13, 2026
·
2 min read
·
Tristan Manalac
Bankruptcy
Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale
August 13, 2026
·
2 min read
·
Tristan Manalac
Job Trends
July’s biopharma layoffs affect 466 employees, a 94% year-over-year drop
August 13, 2026
·
3 min read
·
Angela Gabriel
